{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:45:39Z","timestamp":1791402339276,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Strategy for Biotechnology and Genetic Engineering, Academy of Science and Research (ASRT), Ministry of Higher Education and Scientific Research, Egypt","award":["75D21"],"award-info":[{"award-number":["75D21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Luminal breast cancer (LBC) is the most common subtype of breast cancer affecting women worldwide. Although luminal breast cancer typically has a better prognosis, it mostly responds poorly to neoadjuvant chemotherapy. Non-coding RNAs, especially long non-coding RNAs and microRNAs are crucial in regulating biological processes that contribute to breast cancer development. MALAT1, a long non-coding RNA, is pivotal in the progression of breast cancer. Epithelial-mesenchymal transition (EMT) is critical for cell movement during embryonic development. Clarifying this role could pave various avenues for developing innovative strategies for combating this subtype of malignancy. The present study aimed to investigate the expression profiles and clinical relevance of MALAT1 level and EMT-related miRNAs (miR-17-5p, miR-20a-5p, miR-93-5p, miR-135b-5p, and miR-146a-5p) alongside EMT markers (E-cadherin, N-cadherin, vimentin, fibronectin, twist, SNAI1, Slug, ZEB1, and ZEB2) in LBC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fresh tissues were collected from fifty patients and twenty noncancerous controls. Differential expression of the markers was evaluated using qRT-PCR assay. Spearman Rho test assessed the relationship between the expression levels. Linear regression test evaluated the correlation between the parameters and various clinico-pathological features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results revealed an overall upregulation of MALAT1 in breast cancer tissues although this increase did not reach statistical significance. Overexpression of miR-20a-5p, miR-135b, and ZEB2 was reported, whereas miR146a-5p, ZEB1 and Vimentin levels were suppressed. Correlation analysis demonstrated that miR-20a-5p was positively correlated with SNAI1, E-cadherin, N-cadherin and Slug also it was significantly associated with family history and tumor laterality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that miR-20a-5p plays an oncogenic role in luminal breast cancer by promoting EMT, while MALAT1 may contribute to disease progression through indirect regulatory mechanisms. Finally, MALAT1 and miR-20a-5p might serve as potential therapeutic and prognostic targets in LBC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00339-w","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:02:20Z","timestamp":1769990540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Significance of MALAT1 long non-coding RNA and miR-20a-5p in regulating epithelial mesenchymal transition in luminal breast cancer patients"],"prefix":"10.1186","volume":"38","author":[{"given":"Gehad","family":"Tarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehan","family":"Safwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel Hady","family":"Abdel Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"3","key":"339_CR1","first-page":"287","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ji Y, Liu S, Li J, Wu J, Jin Q, et al. Global burden of female breast cancer: new estimates in 2022, Temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. J Natl Cancer Cent. 2025;5(3):287\u201396. PMID: 40693239; PMCID: PMC12276554.","journal-title":"J Natl Cancer Cent"},{"key":"339_CR2","first-page":"32","volume-title":"Breast cancer","author":"E Orrantia-Borunda","year":"2022","unstructured":"Orrantia-Borunda E, Anchondo-Nu\u00f1ez P, Acu\u00f1a-Aguilar LE, G\u00f3mez-Valles FO, Ram\u00edrez-Valdespino CA. Subtypes of breast cancer. In: Mayrovitz HN, editor. Breast cancer. Brisbane: Exon; 2022. pp. 32\u201349."},{"issue":"1","key":"339_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s42506-019-0026-5","volume":"94","author":"AF Manzour","year":"2019","unstructured":"Manzour AF, Gamal Eldin DA. Awareness about breast cancer and mammogram among women attending outpatient clinics, Ain Shams university Hospitals, Egypt. J Egypt Public Health Assoc. 2019;94(1):26. https:\/\/doi.org\/10.1186\/s42506-019-0026-5. PMID: 32813088; PMCID: PMC7364763.","journal-title":"J Egypt Public Health Assoc"},{"key":"339_CR4","doi-asserted-by":"publisher","unstructured":"Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res. 2005;11(16):5678-85. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2421. PMID: 16115903.","DOI":"10.1158\/1078-0432.CCR-04-2421"},{"issue":"4","key":"339_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/cncr.10741","volume":"95","author":"ER Fisher","year":"2002","unstructured":"Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N. Pathobiology of preoperative chemotherapy: findings from the National surgical adjuvant breast and bowel (NSABP) protocol B-18. Cancer. 2002;95(4):681\u201395. https:\/\/doi.org\/10.1002\/cncr.10741.","journal-title":"Cancer"},{"issue":"7414","key":"339_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature11233","volume":"489","author":"S Djebali","year":"2012","unstructured":"Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, et al. Landscape of transcription in human cells. Nature. 2012;489(7414):101\u20138. https:\/\/doi.org\/10.1038\/nature11233.","journal-title":"Nature"},{"issue":"6","key":"339_CR7","doi-asserted-by":"publisher","first-page":"190096","DOI":"10.1098\/rsob.190096","volume":"9","author":"A Balcerak","year":"2019","unstructured":"Balcerak A, Trebinska-Stryjewska A, Konopinski R, Wakula M, Grzybowska EA. RNA-protein interactions: Disorder, moonlighting, and junk contribute to eukaryotic complexity. Open Biology. 2019;9(6):190096. https:\/\/doi.org\/10.1098\/rsob.190096.","journal-title":"Open Biology"},{"issue":"6","key":"339_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrg3722","volume":"15","author":"KV Morris","year":"2014","unstructured":"Morris KV, Mattick JS. The rise of regulatory RNA. Nat Rev Genet. 2014;15(6):423\u201337. https:\/\/doi.org\/10.1038\/nrg3722.","journal-title":"Nat Rev Genet"},{"issue":"6","key":"339_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904\u201314. https:\/\/doi.org\/10.1016\/j.molcel.2011.08.018.","journal-title":"Mol Cell"},{"issue":"2","key":"339_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/modpathol.2012.160","volume":"26","author":"P Qi","year":"2013","unstructured":"Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013;26(2):155\u201365. https:\/\/doi.org\/10.1038\/modpathol.2012.160.","journal-title":"Mod Pathol"},{"issue":"39","key":"339_CR11","doi-asserted-by":"publisher","first-page":"8031","DOI":"10.1038\/sj.onc.1206928","volume":"22","author":"P Ji","year":"2003","unstructured":"Ji P, Diederichs S, Wang W, B\u00f6ing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin \u03b24 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031\u201341. https:\/\/doi.org\/10.1038\/sj.onc.1206928.","journal-title":"Oncogene"},{"issue":"12","key":"339_CR12","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1080\/15476286.2017.1358347","volume":"14","author":"X Zhang","year":"2017","unstructured":"Zhang X, Hamblin MH, Yin KJ. The long noncoding RNA Malat1: its physiological and pathophysiological functions. RNA Biol. 2017;14(12):1705\u201314. https:\/\/doi.org\/10.1080\/15476286.2017.1358347.","journal-title":"RNA Biol"},{"issue":"2","key":"339_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cancers11020216","volume":"11","author":"Y Sun","year":"2019","unstructured":"Sun Y, Ma L. New insights into long non-coding RNA MALAT1 in cancer and metastasis. Cancers. 2019;11(2):216. https:\/\/doi.org\/10.3390\/cancers11020216.","journal-title":"Cancers"},{"issue":"25","key":"339_CR14","doi-asserted-by":"publisher","first-page":"37957","DOI":"10.18632\/oncotarget.9364","volume":"7","author":"NS Huang","year":"2016","unstructured":"Huang NS, Chi YY, Xue JY, Liu MY, Huang S, Mo M, et al. Long non-coding RNA metastasis-associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with Estrogen receptor and predicts poor survival in breast cancer. Oncotarget. 2016;7(25):37957\u201365. https:\/\/doi.org\/10.18632\/oncotarget.9364.","journal-title":"Oncotarget"},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"e926512","DOI":"10.12659\/MSM.926512","volume":"26","author":"J Yu","year":"2020","unstructured":"Yu J, Jin T, Zhang T. Suppression of long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) potentiates cell apoptosis and drug sensitivity to taxanes and adriamycin in breast cancer. Med Sci Monit. 2020;26:e926512. https:\/\/doi.org\/10.12659\/MSM.926512.","journal-title":"Med Sci Monit"},{"key":"339_CR16","doi-asserted-by":"publisher","unstructured":"Tao S, Bai Z, Liu Y, Gao Y, Zhou J, Zhang Y, et al. Exosomes derived from tumor cells initiate breast cancer cell metastasis and chemoresistance through a MALAT1-dependent mechanism. J Oncol. 2022;5483523. https:\/\/doi.org\/10.1155\/2022\/5483523.","DOI":"10.1155\/2022\/5483523"},{"issue":"1","key":"339_CR17","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/cancers16010234","volume":"16","author":"MA Hussein","year":"2024","unstructured":"Hussein MA, Valinezhad K, Adel E, Munirathinam G. MALAT-1 is a key regulator of epithelial\u2013mesenchymal transition in cancer: a potential therapeutic target for metastasis. Cancers. 2024;16(1):234.","journal-title":"Cancers"},{"key":"339_CR18","doi-asserted-by":"publisher","first-page":"154991","DOI":"10.1016\/j.prp.2023.154991","volume":"253","author":"AA Bhat","year":"2024","unstructured":"Bhat AA, Afzal O, Afzal M, Gupta G, Thapa R, Ali H, Kazmi I, Alzarea SI, Saleem S, Samuel VP, Gubbiyappa SK. MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting. Pathology-Research Pract. 2024;253:154991.","journal-title":"Pathology-Research Pract"},{"issue":"4","key":"339_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u2206\u2206CT method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"2","key":"339_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ncrna6020022","volume":"6","author":"G Arun","year":"2020","unstructured":"Arun G, Aggarwal D, Spector DL. MALAT1 long Non-Coding RNA: functional implications. Non-coding RNA. 2020;6(2):22. https:\/\/doi.org\/10.3390\/ncrna6020022.","journal-title":"Non-coding RNA"},{"issue":"6","key":"339_CR21","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/15476286.2019.1592072","volume":"16","author":"G Arun","year":"2019","unstructured":"Arun G, Spector DL. MALAT1 long non-coding RNA and breast cancer. RNA Biol. 2019;16(6):860\u20133. https:\/\/doi.org\/10.1080\/15476286.2019.1592072.","journal-title":"RNA Biol"},{"issue":"5","key":"339_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/0113892029305656240503045154","volume":"25","author":"MS Hussain","year":"2024","unstructured":"Hussain MS, Agrawal M, Shaikh NK, Saraswat N, Bahl G, Maqbool Bhat M, et al. Beyond the genome: Deciphering the role of MALAT1 in breast cancer progression. Curr Genom. 2024;25(5):343\u201357. https:\/\/doi.org\/10.2174\/0113892029305656240503045154.","journal-title":"Curr Genom"},{"issue":"4","key":"339_CR23","first-page":"418","volume":"46","author":"Y Miao","year":"2016","unstructured":"Miao Y, Fan R, Chen L, Qian H. Clinical significance of long non-coding RNA MALAT1 expression in tissue and serum of breast cancer. Ann Clin Lab Sci. 2016;46(4):418\u201324. PMID: 27466303.","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"339_CR24","first-page":"4881","volume":"8","author":"S Xu","year":"2015","unstructured":"Xu S, Sui S, Zhang J, Bai N, Shi Q, Zhang G, et al. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol. 2015;8(5):4881\u201391. PMID: 26191181.","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"339_CR25","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3390\/cancers12071918","volume":"12","author":"Y Wu","year":"2020","unstructured":"Wu Y, Sarkissyan M, Ogah O, Kim J, Vadgama JV. Expression of MALAT1 promotes trastuzumab resistance in HER2 overexpressing breast cancers. Cancers. 2020;12(7):1918. https:\/\/doi.org\/10.3390\/cancers12071918.","journal-title":"Cancers"},{"issue":"1","key":"339_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bbrc.2016.02.102","volume":"472","author":"J Chou","year":"2016","unstructured":"Chou J, Wang B, Zheng T, Li X, Zheng L, Hu J, et al. MALAT1-induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42. Biochem Biophys Res Commun. 2016;472(1):262\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2016.02.102.","journal-title":"Biochem Biophys Res Commun"},{"key":"339_CR27","doi-asserted-by":"publisher","first-page":"16205","DOI":"10.18632\/oncotarget.7578","volume":"7","author":"T Feng","year":"2016","unstructured":"Feng T, Shao F, Wu Q, Zhang X, Xu D, Qian K, et al. miR-124 downregulation leads to breast cancer progression via lncRNA-MALAT1 regulation and CDK4\/E2F1 signal activation. Oncotarget. 2016;7:16205\u201316. https:\/\/doi.org\/10.18632\/oncotarget.7578.","journal-title":"Oncotarget"},{"issue":"10","key":"339_CR28","first-page":"3186","volume":"10","author":"Z Li","year":"2018","unstructured":"Li Z, Xu L, Liu Y, Fu S, Tu J, Hu Y, et al. LncRNA MALAT1 promotes relapse of breast cancer patients with postoperative fever. Am J Translational Res. 2018;10(10):3186\u201397.","journal-title":"Am J Translational Res"},{"issue":"12","key":"339_CR29","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang Y, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50(12):1705\u201315. https:\/\/doi.org\/10.1038\/s41588-018-0252-3.","journal-title":"Nat Genet"},{"key":"339_CR30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12935-018-0606-z","volume":"18","author":"J Li","year":"2018","unstructured":"Li J, Cui Z, Li H, Lv X, Gao M, Yang Z, et al. Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis. Cancer Cell Int. 2018;18:109. https:\/\/doi.org\/10.1186\/s12935-018-0606-z. PMID: 30093838; PMCID: PMC6080354.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"339_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41420-023-01448-4","volume":"9","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Du W, Huang Z, Wu S, Ou X, Zhang J, et al. Hsa_circ_0060467 promotes breast cancer liver metastasis by complexing with eIF4A3 and sponging miR-1205. Cell Death Discov. 2023;9(1):153. https:\/\/doi.org\/10.1038\/s41420-023-01448-4. PMID: 37160894; PMCID: PMC10169853.","journal-title":"Cell Death Discov"},{"issue":"10","key":"339_CR32","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.7150\/jca.111680","volume":"16","author":"Q Bao","year":"2025","unstructured":"Bao Q, Zhang H, Chen P, Wu S, Zou Y, Wang H, et al. The dual roles of circular RNAs in breast cancer distant metastasis and their clinical applications. J Cancer. 2025;16(10):3270\u201382. https:\/\/doi.org\/10.7150\/jca.111680. PMID: 40740236; PMCID: PMC12305621.","journal-title":"J Cancer"},{"key":"339_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/CMAR.S144619","volume":"10","author":"K Liu","year":"2018","unstructured":"Liu K, Zhang W, Dai Z, Wang M, Tian T, Liu X, et al. Association between body mass index and breast cancer risk: evidence based on a dose-response meta-analysis. Cancer Manage Res. 2018;10:143\u201351. https:\/\/doi.org\/10.2147\/CMAR.S144619.","journal-title":"Cancer Manage Res"},{"key":"339_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.trsl.2017.09.001","volume":"190","author":"F Leti","year":"2017","unstructured":"Leti F, Legendre C, Still CD, Chu X, Petrick A, Gerhard GS, et al. Altered expression of MALAT1 LncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells. Translational Res. 2017;190:25\u2013e3921. https:\/\/doi.org\/10.1016\/j.trsl.2017.09.001.","journal-title":"Translational Res"},{"issue":"4","key":"339_CR35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.41158","volume":"72","author":"DE Nanus","year":"2020","unstructured":"Nanus DE, Wijesinghe SN, Pearson MJ, Hadjicharalambous MR, Rosser A, Davis ET, et al. Regulation of the inflammatory synovial fibroblast phenotype by metastasis-associated lung adenocarcinoma transcript 1 long noncoding RNA in obese patients with osteoarthritis. Arthritis Rheumatol. 2020;72(4):609\u201319. https:\/\/doi.org\/10.1002\/art.41158.","journal-title":"Arthritis Rheumatol"},{"key":"339_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.omtn.2019.08.002","volume":"18","author":"SX Liu","year":"2019","unstructured":"Liu SX, Zheng F, Xie KL, Xie MR, Jiang LJ, Cai Y. Exercise reduces insulin resistance in type 2 diabetes mellitus via mediating the LncRNA MALAT1\/microRNA-382-3p\/resistin axis. Mol Therapy - Nucleic Acids. 2019;18:34\u201344. https:\/\/doi.org\/10.1016\/j.omtn.2019.08.002.","journal-title":"Mol Therapy - Nucleic Acids"},{"key":"339_CR37","doi-asserted-by":"publisher","first-page":"100647","DOI":"10.1016\/j.ctarc.2022.100647","volume":"33","author":"W Zhao","year":"2022","unstructured":"Zhao W, Gupta A, Krawczyk J, Gupta S. The miR-17-92 cluster: Yin and Yang in human cancers. Cancer Treat Res Commun. 2022;33:100647. https:\/\/doi.org\/10.1016\/j.ctarc.2022.100647.","journal-title":"Cancer Treat Res Commun"},{"key":"339_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cellsig.2018.08.004","volume":"51","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhao Y, He Y, Li Q, Mao Y. The functional pathway analysis and clinical significance of miR-20a and its related LncRNAs in breast cancer. Cell Signal. 2018;51:152\u201365. https:\/\/doi.org\/10.1016\/j.cellsig.2018.08.004.","journal-title":"Cell Signal"},{"key":"339_CR39","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.biopha.2018.04.165","volume":"103","author":"X Bai","year":"2018","unstructured":"Bai X, Han G, Liu Y, Jiang H, He Q. MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3. Biomed Pharmacother. 2018;103:1482\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.165.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"339_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13046-023-02783-1","volume":"42","author":"X Gao","year":"2023","unstructured":"Gao X, Qin T, Mao J, Zhang J, Fan S, Lu Y, et al. Correction: PTENP1\/miR-20a\/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K\/AKT pathway. J Experimental Clin Cancer Res. 2023;42(1):202. https:\/\/doi.org\/10.1186\/s13046-023-02783-1.","journal-title":"J Experimental Clin Cancer Res"},{"issue":"12","key":"339_CR41","doi-asserted-by":"publisher","first-page":"5687","DOI":"10.1002\/cam4.2454","volume":"8","author":"L Guo","year":"2019","unstructured":"Guo L, Zhu Y, Li L, Zhou S, Yin G, Yu G, et al. Breast cancer cell-derived Exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1. Cancer Med. 2019;8(12):5687\u2013701. https:\/\/doi.org\/10.1002\/cam4.2454.","journal-title":"Cancer Med"},{"key":"339_CR42","doi-asserted-by":"publisher","unstructured":"Yang H, Chen Z, Liu Z. MiR-20a-5p negatively regulates NR4A3 to promote metastasis in bladder cancer. J Oncol. 2021;1377989. https:\/\/doi.org\/10.1155\/2021\/1377989.","DOI":"10.1155\/2021\/1377989"},{"issue":"17","key":"339_CR43","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/CM9.0000000000001975","volume":"135","author":"X Wang","year":"2022","unstructured":"Wang X, Wei P, Yang L, Liu F, Tong X, Yang X, et al. MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3. Chin Med J. 2022;135(17):2089\u201397. https:\/\/doi.org\/10.1097\/CM9.0000000000001975.","journal-title":"Chin Med J"},{"issue":"1","key":"339_CR44","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12967-019-2086-x","volume":"17","author":"L Moi","year":"2019","unstructured":"Moi L, Braaten T, Al-Shibli K, Lund E, Busund LR. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian women and cancer (NOWAC) study. J Translational Med. 2019;17(1):334. https:\/\/doi.org\/10.1186\/s12967-019-2086-x.","journal-title":"J Translational Med"},{"issue":"5","key":"339_CR45","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.26355\/eurrev_202003_20522","volume":"24","author":"QY Fang","year":"2020","unstructured":"Fang QY, Deng QF, Luo J, Zhou CC. MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9. Eur Rev Med Pharmacol Sci. 2020;24(5):2548\u201356. https:\/\/doi.org\/10.26355\/eurrev_202003_20522.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00339-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00339-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00339-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:02:22Z","timestamp":1769990542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00339-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00339-w","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and was approved by the Baheya-Research Ethical Committee, Baheya Foundation for Early Detection & Treatment of Breast Cancer, Egypt (IRB#00012829). All participants provided written informed consent before participating in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"I would like to declare that the corresponding author (Prof. Abdel Hady A. Abdel Wahab) is an Associate Editor of the journal, but has no role in handling the manuscript. The rest of the authors have no conflict of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}